Trials / Recruiting
RecruitingNCT05317026
Increased Early Pain Relief by Adding Vertebroplasty to SBRT
Pre-irradiation Vertebroplasty in Patients With Spine Metastases Candidates for SBRT vs SBRT Alone: Increased Early Pain Relief
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of treating metastases is to preserve stability and neurological function while reducing pain. The actual standard of care is stereotaxic body radiation therapy (SBRT) alone in non-surgical patients. The added value of vertebroplasty to SBRT is not well documented in the literature, nor whether performing vertebroplasty before radiotherapy treatment leads to a reduction in the rate of fractures and post-SBRT pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Vertebroplasty | SBRT consists of radiotherapy treatments hypofractionated in 1 to 5 fractions, at doses considered curative at a precise target volume. The vertebroplasty will be performed according to the usual procedure at the center in the angiography suite under local anesthesia and conscious sedation * Introduction of a vertebral needle, under biplanar fluoroscopic guidance, polymethylmethacrylate (PMMA) cement injection. * Cone-beam volume-CT at the end of the procedure, with the angiography table and c-arm, to evaluate the cement distribution and detect any leak. * Decubitus position for 2 hours following procedure, then hospital discharge on the same day. |
| PROCEDURE | Stereotactic Body Radiation Therapy only | SBRT consists of radiotherapy treatments hypofractionated in 1 to 5 fractions, at doses considered curative at a precise target volume |
Timeline
- Start date
- 2023-11-22
- Primary completion
- 2025-12-31
- Completion
- 2027-12-31
- First posted
- 2022-04-07
- Last updated
- 2024-08-07
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT05317026. Inclusion in this directory is not an endorsement.